Diseño y fabricación de una antena con diversidad en polarización para redes WIFI a 2,4 GHz

Existeixen diferents tecnologies de transmissió sense fils, però la més coneguda és la tecnologia WIFI (Wireless Fidelity) que opera a la banda dels 2,4 GHz a Europa. Aquest tipus de xarxes opera en entorns indoor, on el canal està sotmès a una aleatorietat i complexitat elevades degut a la presència d’una gran quantitat d’elements que poden fer que la senyal rebuda presenti variacions importants en les seves característiques (nivell de senyal, polarització...). Aquest fet motiva la necessitat de desenvolupar i implantar sistemes de comunicacions amb solucions per poder minimitzar els efectes provocats per l’entorn a la senyal. Per poder pal·liar aquestes variacions, en aquest projecte s’ha dissenyat i fabricat una antena formada per dos dipols disposats un ortogonal a l’altre de manera que existeixi diversitat en polarització. La freqüència de treball de la antena és de 2,4 GHz. Rebuda una senyal de RF, el circuit de commutació permetrà seleccionar el dipol pel qual es rep la senyal de RF amb una major potència.

Anti-leishmanial and structure-activity relationship of ring substituted 3-phenyl-1-(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivatives

A series of ring substituted 3-phenyl-1-(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivatives were synthesized and tested for in vitro leishmanicidal activity against amastigotes of Leishmania amazonensis in axenical cultures and murine infected macrophages. Structure-activity relationships demonstrated the importance of a radical methoxy at position R3', R4' and R5'. (2E)-3-(3,4,5-trimethoxy-phenyl)-1-(3,6,7-trimethyl-1,4-dioxy-quinoxalin-2-yl)-propenone was the most active. Cytotoxicity on macrophages revealed that this product was almost six times more active than toxic.

Tracing lineage by phenotypic and genotypic markers in Salmonella enterica subsp. enterica serovar 1,4,[5],12:i:- and Salmonella Typhimurium isolated in state of São Paulo, Brazil

Fifty-three Salmonella 1,4,[5],12:i:- and 45 Salmonella Typhimurium strains were characterised using phage typing, plasmid profiles and pulsed-field gel electrophoresis (PFGE) for comparison. The majority of the strains were subdivided into definitive type (DT) 41 (22.6%) and DT 193 (18%) and the 60-MDa plasmid was detected in 94.3% and 84.4% of strains, respectively. Genetic diversity was observed among all strains and 90% presented a > 70% similarity through PFGE analysis. These results suggest a close relationship between Salmonella 1,4,[5],12:i:- and Salmonella Typhimurium at the serotype level.

Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols.

New derivatives of 1,4-dideoxy-1,4-imino-D-ribitol have been prepared and evaluated for their cytotoxicity on solid and haematological malignancies. 1,4-Dideoxy-5-O-[(9Z)-octadec-9-en-1-yl]-1,4-imino-D-ribitol (13, IC(50) ∼2 μM) and its C(18)-analogues (IC(50) <10 μM) are cytotoxic toward SKBR3 (breast cancer) cells. 13 also inhibits (IC(50) ∼8 μM) growth of JURKAT cells.

A non-interventional phase IV Belgian survey to assess the antiviral effectiveness of pegylated interferon-alpha-2b and ribavirin treatment according to the stage of liver fibrosis in previously untreated patients with genotype 1/4/5/6 chronic hepatitis C (PRACTICE).

BACKGROUND AND STUDY AIMS: This was an observational, non-interventional, multicenter, phase IV study, in patients with genotype 1/4/5/6 chronic hepatitis C (CHC). The primary objectives were to evaluate SVR in patients with no or minimal fibrosis (METAVIR F0-F1) versus well established fibrosis (F2-F4), and to estimate response on Weeks 12, 24 and 48 on treatment in previously untreated patients with genotypes 1/4/5/6 CHC. PATIENTS AND METHODS: 538 patients treated with pegylated interferon alfa 2b 1.5 mcg/kg in combination with ribavirin 800-1200 mg/day were enrolled in 55 sites in Belgium and Luxembourg, 505 being considered for the analysis. 40% of the patients were female and 60% male, the average age was 47.5 years, 10.5% were 65 or older. RESULTS: SVR was observed in 35% of the patients, EVR in 68%, of which pEVR in 33% and cEVR in 35%. SVR was observed in 43% of the low fibrosis group (F0, F1) and 30% of the high fibrosis group (F2, F3, F4) (p = 0.005). SVR rates were 34% for genotype 1, 37% for genotype 4, and 47% for genotype 5 (NS). Multivariate analysis showed that EVR and baseline METAVIR score are independent prognostic factors for SVR. CONCLUSIONS: This trial confirms that fibrosis stage and early viral response are the most important key-factors to predict sustained response, suggesting that the earlier patients are treated, the better the outcome. Non-invasive techniques enable us to closely monitor progression of fibrosis, allowing a better selection of patients for antiviral treatment in the DAA-era.

Aventures d'amour et d'épée sous Henri IV ; 1-4. Le capitaine Bel-Coeur. Vol. 3 / Georges Spitzmuller

Collection : Le livre national ; n° 321-324

Aventures d'amour et d'épée sous Henri IV ; 1-4. Le capitaine Bel-Coeur. Vol. 4 / Georges Spitzmuller

Collection : Le livre national ; n° 321-324

Rouva Alli Paasikivi 1/4 1958

Kirje

Tasavallan Presidentti Urho Kekkosen vierailu Tshekkoslovakiaan 1.-4.10.1969 (Tasavallan Presidentin Tshekkoslovakiaan saapumispuhe 1.10.1969)

Puhe

Berlin 1/4 -32

Kirje 1.4.1932